Canada Wants Data on 200 Chemicals. The Hard Part May Be Finding It Across Your Supply Chain
Canada launches mandatory CEPA section 71 reporting for 200 priority substances, with Phase 1 responses due March 3, 2027.
Category: Flash News
A Clear IV Solution Can Still Carry a Serious Quality Risk
Baxter recalls two saline lots for potential fiberglass particulate contamination, raising injectable particulate-control questions
Your Test Report Is Current. Is the Standard Behind It Still Current?
TL;DR What FDA Changed FDA’s Recognition List Number 066 modifies the list of voluntary consensus standards it recognizes for use in medical-device regulatory work. The Federal Register notice explains that manufacturers may use recognized standards and declarations of conformity to help address certain premarket requirements. CDRH listed the update among…
The Software Updated Successfully – did the Patient’s Alarm Settings Survive?
TL;DR FDA says GE reported that during an update of Portrait Core Services software, some patients monitored using Portrait Mobile devices were discharged removed from the monitoring system. FDA also says alarm settings may reset to factory defaults following the update. That creates the possibility that the hardware appears operational…
FDA Eases Biosimilar Rules, Saves $20M in Costs
FDA’s 4th draft guidance revision streamlines biosimilar PK testing, allowing non-U.S. comparators with analytical justification to cut $20M costs and speed approvals.
76% Healthcare AI Pilots Stall on Regs
Explore why 76% of healthcare AI pilots stall due to regulatory gaps in HIPAA, EU AI Act, FDA rules. Learn compliance strategies and governance best practices for safe scaling.
FDA Top Regulator Exit Hits Pharma Profits
Explore how Vinay Prasad’s resignation from FDA’s CBER amid regulatory clashes disrupts pharma profits, rare disease approvals, and vaccine strategies. Analyze impacts, compliance shifts, and future enforcement.
Zero‑Day Attacks on Enterprise Software Reach Record High
Google reports 48% of 2025 zero-days targeted enterprise software—an all-time high. Explore regulatory requirements, compliance obligations, and critical security measures organizations must implement.
State Laws Challenge Federal Banking Shield on Escrow
Explore how state laws are challenging federal pre-emption in escrow and product labeling, turning compliance into a major risk factor for businesses amid Supreme Court scrutiny.
Non-compliance tax: Avoid $20K Fines – Compliance’s 13:1 ROI Secret
Discover how transforming regulatory checks into a 13:1 ROI shields businesses from $20K fines and operational chaos. Learn proven strategies to calculate non-compliance tax costs and unlock compliance value.